Skip to content

Medical emergency? What to do

Alzheimer's May be Insulin-Dependent Disease

3-RXPublished December 2, 20053 min read

Key points

  • Insulin and associated signaling molecules begin to disappear from the brain during early Alzheimer's, suggesting the possibility of therapy to boost levels of insulin in the brain, researchers here reported.
  • The researchers analyzed postmortem brain tissue from 45 patients with a diagnosis of either normal aging or Alzheimer's.
  • Further tests on cultured human neuronal cells revealed that insulin and IGF-I stimulate the expression of ChAT, leading the researchers to speculate that acetylcholine deficiency may be caused by declining levels of insulin and IGF-I.
  • "From the standpoint of therapeutic intervention, treatment with ligands that specifically enhance insulin/IGF-I/IGF-II signaling mechanisms in the brain may help to improve viability and function of neuronal cells at risk for Alzheimer's disease-type neurodegeneration," the researchers suggested.

Insulin and associated signaling molecules begin to disappear from the brain during early Alzheimer's, suggesting the possibility of therapy to boost levels of insulin in the brain, researchers here reported. They call Alzheimer's "type 3 diabetes."

Mean levels of insulin, the signaling molecule insulin-like growth factor I (IGF-I), and its receptor decline significantly in the brain during the early stages of Alzheimer's, compared with normal controls, and decrease by 80% or more in late-stage disease, according to Suzanne M. de la Monte, M.D., and colleagues at Brown Medical School here.

Levels of insulin-like growth factor II (IGF-II ) and its receptor also decline during the early stages of Alzheimer's, but less dramatically, falling to about 50% of normal in late-stage disease, Dr. de la Monte and colleagues reported in the November issue of the Journal of Alzheimer's Disease.

The researchers analyzed postmortem brain tissue from 45 patients with a diagnosis of either normal aging or Alzheimer's. Samples from patients with Alzheimer's were histologically graded according to disease severity.

The researchers also found that levels of the enzyme choline acetyltransferase (ChAT), which is responsible for making acetylcholine, were 65% to 70% lower in samples from late-stage disease than normal controls. Acetylcholine deficiency has been linked to dementia and has long been recognized as an early abnormality in Alzheimer's.

Further tests on cultured human neuronal cells revealed that insulin and IGF-I stimulate the expression of ChAT, leading the researchers to speculate that acetylcholine deficiency may be caused by declining levels of insulin and IGF-I.

"Altogether, the results suggest that impairments in insulin, IGF-I, and IGF-II stimulated signaling and associated reductions in energy metabolism (ATP) and ChAT expression represent major abnormalities that develop early in the course of Alzheimer's disease and progress with severity of neurodegeneration," the researchers said.

Furthermore, the findings "support our hypothesis that Alzheimer's disease represents a neuroendocrine disease that shares features with Types 1 and 2 diabetes mellitus, and which we refer to as 'type 3 diabetes,'" they concluded.

"From the standpoint of therapeutic intervention, treatment with ligands that specifically enhance insulin/IGF-I/IGF-II signaling mechanisms in the brain may help to improve viability and function of neuronal cells at risk for Alzheimer's disease-type neurodegeneration," the researchers suggested.

Implanted stem cells that deliver a continuous source of insulin or associated signaling molecules might one day become an effective long-term therapy for Alzheimer's, they said.

Source: Journal of Alzheimer's Disease

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underDiabetes

Keep reading

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.